Agency Information Collection Activities: Submission for OMB Review; Comment Request, 16270-16271 [2013-05802]
Download as PDF
16270
Federal Register / Vol. 78, No. 50 / Thursday, March 14, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
respondents
Type of respondent
Form name
Laboratorians ....................
National Laboratory Training Network Registration Form (Attachment 3).
Dated: March 7, 2013.
Ron A. Otten,
Director, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
[FR Doc. 2013–05821 Filed 3–13–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–484, CMS–10152,
CMS–10449]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Reinstatement of a previously
approved collection; Title: Attending
Physician’s Certification of Medical
Necessity for Home Oxygen Therapy
and Supporting Documentation
Requirements; Use: Under Section
1862(a)(1)(A) of the Social Security Act
(the Act), 42 U.S.C. 1395y(a), the
Secretary may only pay for items and
services that are ‘‘reasonable and
necessary for the diagnosis or treatment
tkelley on DSK3SPTVN1PROD with NOTICES
AGENCY:
VerDate Mar<15>2010
16:51 Mar 13, 2013
Jkt 229001
of illness or injury or to improve the
functioning of a malformed body
member.’’ In order to assure this, CMS
and its contractors develop Medical
policies that specify the circumstances
under which an item or service can be
covered. The certificate of medical
necessity (CMN) provides a mechanism
for suppliers of Durable Medical
Equipment, defined in 42 U.S.C. 1395x
(n), and Medical Equipment and
Supplies defined in 42 U.S.C. 1395j(5),
to demonstrate that the item being
provided meets the criteria for Medicare
coverage. Section 1833(e), 42 U.S.C.
1395l(e), provides that no payment can
be made to any provider of services, or
other person, unless that person has
furnished the information necessary for
Medicare or its contractor to determine
the amounts due to be paid. Certain
individuals can use a CMN to furnish
this information, rather than having to
produce large quantities of medical
records for every claim they submit for
payment. Under Section 1834(j)(2) of
the Act, 42 U.S.C. 1395m(j)(2), suppliers
of DME items are prohibited from
providing medical information to
physicians when a CMN is being
completed to document medical
necessity. The physician who orders the
item is responsible for providing the
information necessary to demonstrate
that the item provided is reasonable and
necessary and the supplier shall also list
on the CMN the fee schedule amount
and the suppliers charge for the medical
equipment or supplies being furnished
prior to distribution of such certificate
to the physician. Any supplier of
medical equipment who knowingly and
willfully distributes a CMN in violation
of this restriction is subject to penalties,
including civil money penalties (42
U.S.C. 1395m(j)(2)(A)(iii)). Under title
42 of the Code of Federal Regulations,
§§ 410.38 and 424.5, Medicare has the
legal authority to collect sufficient
information to determine payment for
oxygen, and oxygen equipment. Oxygen
and oxygen equipment is by far the
largest single total charge of all items
paid under durable medical equipment
coverage authority. Detailed criteria
concerning coverage of home oxygen
therapy are found in Medicare Carriers
Manual Chapter II—Coverage Issues
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
6,500
1
Average
burden per
response
(hours)
5/60
Appendix, Section 60–4. For Medicare
to consider any item for coverage and
payment, the information submitted by
the supplier (e.g., claims and CMNs),
including documentation in the
patient’s medical records must
corroborate that the patient meets
Medicare coverage criteria. The patient’s
medical records may include:
physician’s office records; hospital
records; nursing home records; home
health agency records; records from
other healthcare professionals or test
reports. This documentation must be
available to the DME MACs upon
request. Form Number: CMS–484 (OCN:
0938–0534); Frequency: Occasionally;
Affected Public: Private Sector: Business
or other for-profits, Not-for-profits;
Number of Respondents: 8,880; Total
Annual Responses: 1,541,359; Total
Annual Hours: 308,271. (For policy
questions regarding this collection
contact Doris Jackson at 410–786–4459.
For all other issues call 410–786–1326.)
2. Type of Information Collection
Request: Reinstatement of a previously
approved collection; Title: Data
Collection for Medicare Beneficiaries
Receiving NaF–18 Positron Emission
Tomography (PET) to Identify Bone
Metastasis in Cancer; Use: In Decision
Memorandum #CAG–00065R, issued on
February 26, 2010, the Centers for
Medicare and Medicaid Services (CMS)
determined that the evidence is
sufficient to conclude that for Medicare
beneficiaries receiving NaF–18 PET scan
to identify bone metastasis in cancer is
reasonable and necessary only when the
provider is participating in and patients
are enrolled in a clinical study designed
to information at the time of the scan to
assist in initial antitumor treatment
planning or to guide subsequent
treatment strategy by the identification,
location and quantification of bone
metastases in beneficiaries in whom
bone metastases are strongly suspected
based on clinical symptoms or the
results of other diagnostic studies.
Qualifying clinical studies must ensure
that specific hypotheses are addressed;
appropriate data elements are collected;
hospitals and providers are qualified to
provide the PET scan and interpret the
results; participating hospitals and
providers accurately report data on all
E:\FR\FM\14MRN1.SGM
14MRN1
tkelley on DSK3SPTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 50 / Thursday, March 14, 2013 / Notices
Medicare enrolled patients; and all
patient confidentiality, privacy, and
other Federal laws must be followed.
Consistent with section 1142 of the
Social Security Act (the Act), the
Agency for Healthcare Research and
Quality (AHRQ) supports clinical
research studies that CMS determines
meets specified standards and address
the specified research questions. To
qualify for payment, providers must
prescribe certain NaF–18 PET scans for
beneficiaries with a set of clinical
criteria specific to each solid tumor. The
statuary authority for this policy is
section 1862(a)(1)(E) of the Act. The
need to prospectively collect
information at the time of the scan is to
assist the provider in decision making
for patient management. Form Number:
CMS–10152 (OCN: 0938–0968);
Frequency: Annual; Affected Public:
Private Sector—Business or other forprofits; Number of Respondents: 25000;
Total Annual Responses: 25000; Total
Annual Hours: 2,084 hours. (For policy
questions regarding this collection
contact Stuart Caplan at 410–786–8564.
For all other issues call 410–786–1326.)
3. Type of Information Collection
Request: Revision; Title of Information
Collection: Recognized Accrediting
Entities Data Collection; Use: The final
rule that was released on July 20, 2012
(77 FR 42658) establishes a process for
recognizing accrediting entities for the
purposes of implementing section
1311(c)(1)(D)(i) of the Affordable Care
Act. In order for a health plan to be
certified as a QHP and operate in an
Exchange, it must be accredited by an
accrediting entity that has been
recognized by the Secretary of Health
and Human Services. The final rule
establishes the first phase of a twophased process for recognition of
accrediting entities. In phase one, the
National Committee for Quality
Assurance (NCQA) and URAC were
recognized as accrediting entities for the
purposes of fulfilling the accreditation
requirement as part of qualified health
plan certification. In a subsequent final
rule, released February 22, 2013, we
amended the first phase of this process
to allow additional accrediting entities
to apply to be recognized. The
assessment used to assess these
additional accrediting entities will be
the same as the assessment underlying
the recognition of NCQA and URAC.
This information collection is necessary
to ensure that the recognized accrediting
entities meet the proposed conditions.
45 CFR 156.275(c) requires that the
accrediting entities provide
accreditation survey data elements,
including accreditation status,
VerDate Mar<15>2010
16:51 Mar 13, 2013
Jkt 229001
accreditation score, accreditation
expiration date, clinical quality measure
results and adult and child CAHPS
measure survey results to the Exchanges
once these data are released by the
issuers. Further, accrediting entities
applying to be recognized must provide
to HHS the accreditation standards and
requirements, processes, and measure
specifications for performance measures
and, once recognized, any proposed
changes or updates to these standards,
and requirements, processes and
measure specifications with 60-day
notice prior to public notification. This
collection, which is approved under
OCN: 0938–1176), is necessary in order
for Exchanges to verify that the QHPs
being offered in their Exchange meet the
accreditation requirement and are high
quality plans.
The 60-day Federal Register notice
published on November 23, 2012 (77 FR
70163). We received two comments. The
comments concerned issuer burden
associated with the data collection and
the content of the data submission.
These comments were addressed in full
in the Patient Protection and Affordable
Care Act; Standards Related to Essential
Health Benefits, Actuarial Value, and
Accreditation Final Rule. Generally, we
noted that this data collection pertained
to the submission of data from
accrediting entities seeking to be
recognized and accrediting entities
already recognized, rather than issuers.
Comments related to the content of the
data submission were deemed out of
scope. Form Number: CMS–10449;
Frequency: Monthly, Occasionally;
Affected Public: Private sector, Not-forprofit institutions; Number of
Respondents: 4; Number of Responses:
60; Total Annual Hours: 3,544. (For
policy questions regarding this
collection contact Rebecca
Zimmermann at (301) 492–4396. For all
other issues, call (410) 786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on April 15, 2013: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
16271
Number: (202) 395–6974, Email:
OIRA_submission@omb.eop.gov.
Dated: March 8, 2013.
Martique Jones,
Deputy Director, Regulations Development
Group, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2013–05802 Filed 3–13–13; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–0001]
Joint Meeting of the Advisory
Committee for Reproductive Health
Drugs and the Drug Safety and Risk
Management Advisory Committee;
Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committees: Advisory
Committee for Reproductive Health
Drugs and the Drug Safety and Risk
Management Advisory Committee.
General Function of the Committees:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on April 18, 2013, from 8 a.m. to
5 p.m.
Location: FDA White Oak Campus,
10903 New Hampshire Ave., Bldg. 31
Conference Center, the Great Room (rm.
1503), Silver Spring, MD 20993–0002.
Information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/default.htm; under
the heading ‘‘Resources for You,’’ click
on ‘‘Public Meetings at the FDA White
Oak Campus.’’ Please note that visitors
to the White Oak Campus must enter
through Building 1.
Contact Person: Kalyani Bhatt, Center
for Drug Evaluation and Research, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, Fax: 301–847–8533, email:
ACRHD@fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area). A notice in the
Federal Register about last minute
modifications that impact a previously
E:\FR\FM\14MRN1.SGM
14MRN1
Agencies
[Federal Register Volume 78, Number 50 (Thursday, March 14, 2013)]
[Notices]
[Pages 16270-16271]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-05802]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier CMS-484, CMS-10152, CMS-10449]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS) is publishing the following summary of proposed
collections for public comment. Interested persons are invited to send
comments regarding this burden estimate or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
1. Type of Information Collection Request: Reinstatement of a
previously approved collection; Title: Attending Physician's
Certification of Medical Necessity for Home Oxygen Therapy and
Supporting Documentation Requirements; Use: Under Section 1862(a)(1)(A)
of the Social Security Act (the Act), 42 U.S.C. 1395y(a), the Secretary
may only pay for items and services that are ``reasonable and necessary
for the diagnosis or treatment of illness or injury or to improve the
functioning of a malformed body member.'' In order to assure this, CMS
and its contractors develop Medical policies that specify the
circumstances under which an item or service can be covered. The
certificate of medical necessity (CMN) provides a mechanism for
suppliers of Durable Medical Equipment, defined in 42 U.S.C. 1395x (n),
and Medical Equipment and Supplies defined in 42 U.S.C. 1395j(5), to
demonstrate that the item being provided meets the criteria for
Medicare coverage. Section 1833(e), 42 U.S.C. 1395l(e), provides that
no payment can be made to any provider of services, or other person,
unless that person has furnished the information necessary for Medicare
or its contractor to determine the amounts due to be paid. Certain
individuals can use a CMN to furnish this information, rather than
having to produce large quantities of medical records for every claim
they submit for payment. Under Section 1834(j)(2) of the Act, 42 U.S.C.
1395m(j)(2), suppliers of DME items are prohibited from providing
medical information to physicians when a CMN is being completed to
document medical necessity. The physician who orders the item is
responsible for providing the information necessary to demonstrate that
the item provided is reasonable and necessary and the supplier shall
also list on the CMN the fee schedule amount and the suppliers charge
for the medical equipment or supplies being furnished prior to
distribution of such certificate to the physician. Any supplier of
medical equipment who knowingly and willfully distributes a CMN in
violation of this restriction is subject to penalties, including civil
money penalties (42 U.S.C. 1395m(j)(2)(A)(iii)). Under title 42 of the
Code of Federal Regulations, Sec. Sec. 410.38 and 424.5, Medicare has
the legal authority to collect sufficient information to determine
payment for oxygen, and oxygen equipment. Oxygen and oxygen equipment
is by far the largest single total charge of all items paid under
durable medical equipment coverage authority. Detailed criteria
concerning coverage of home oxygen therapy are found in Medicare
Carriers Manual Chapter II--Coverage Issues Appendix, Section 60-4. For
Medicare to consider any item for coverage and payment, the information
submitted by the supplier (e.g., claims and CMNs), including
documentation in the patient's medical records must corroborate that
the patient meets Medicare coverage criteria. The patient's medical
records may include: physician's office records; hospital records;
nursing home records; home health agency records; records from other
healthcare professionals or test reports. This documentation must be
available to the DME MACs upon request. Form Number: CMS-484 (OCN:
0938-0534); Frequency: Occasionally; Affected Public: Private Sector:
Business or other for-profits, Not-for-profits; Number of Respondents:
8,880; Total Annual Responses: 1,541,359; Total Annual Hours: 308,271.
(For policy questions regarding this collection contact Doris Jackson
at 410-786-4459. For all other issues call 410-786-1326.)
2. Type of Information Collection Request: Reinstatement of a
previously approved collection; Title: Data Collection for Medicare
Beneficiaries Receiving NaF-18 Positron Emission Tomography (PET) to
Identify Bone Metastasis in Cancer; Use: In Decision Memorandum
CAG-00065R, issued on February 26, 2010, the Centers for
Medicare and Medicaid Services (CMS) determined that the evidence is
sufficient to conclude that for Medicare beneficiaries receiving NaF-18
PET scan to identify bone metastasis in cancer is reasonable and
necessary only when the provider is participating in and patients are
enrolled in a clinical study designed to information at the time of the
scan to assist in initial antitumor treatment planning or to guide
subsequent treatment strategy by the identification, location and
quantification of bone metastases in beneficiaries in whom bone
metastases are strongly suspected based on clinical symptoms or the
results of other diagnostic studies. Qualifying clinical studies must
ensure that specific hypotheses are addressed; appropriate data
elements are collected; hospitals and providers are qualified to
provide the PET scan and interpret the results; participating hospitals
and providers accurately report data on all
[[Page 16271]]
Medicare enrolled patients; and all patient confidentiality, privacy,
and other Federal laws must be followed. Consistent with section 1142
of the Social Security Act (the Act), the Agency for Healthcare
Research and Quality (AHRQ) supports clinical research studies that CMS
determines meets specified standards and address the specified research
questions. To qualify for payment, providers must prescribe certain
NaF-18 PET scans for beneficiaries with a set of clinical criteria
specific to each solid tumor. The statuary authority for this policy is
section 1862(a)(1)(E) of the Act. The need to prospectively collect
information at the time of the scan is to assist the provider in
decision making for patient management. Form Number: CMS-10152 (OCN:
0938-0968); Frequency: Annual; Affected Public: Private Sector--
Business or other for-profits; Number of Respondents: 25000; Total
Annual Responses: 25000; Total Annual Hours: 2,084 hours. (For policy
questions regarding this collection contact Stuart Caplan at 410-786-
8564. For all other issues call 410-786-1326.)
3. Type of Information Collection Request: Revision; Title of
Information Collection: Recognized Accrediting Entities Data
Collection; Use: The final rule that was released on July 20, 2012 (77
FR 42658) establishes a process for recognizing accrediting entities
for the purposes of implementing section 1311(c)(1)(D)(i) of the
Affordable Care Act. In order for a health plan to be certified as a
QHP and operate in an Exchange, it must be accredited by an accrediting
entity that has been recognized by the Secretary of Health and Human
Services. The final rule establishes the first phase of a two-phased
process for recognition of accrediting entities. In phase one, the
National Committee for Quality Assurance (NCQA) and URAC were
recognized as accrediting entities for the purposes of fulfilling the
accreditation requirement as part of qualified health plan
certification. In a subsequent final rule, released February 22, 2013,
we amended the first phase of this process to allow additional
accrediting entities to apply to be recognized. The assessment used to
assess these additional accrediting entities will be the same as the
assessment underlying the recognition of NCQA and URAC. This
information collection is necessary to ensure that the recognized
accrediting entities meet the proposed conditions. 45 CFR 156.275(c)
requires that the accrediting entities provide accreditation survey
data elements, including accreditation status, accreditation score,
accreditation expiration date, clinical quality measure results and
adult and child CAHPS measure survey results to the Exchanges once
these data are released by the issuers. Further, accrediting entities
applying to be recognized must provide to HHS the accreditation
standards and requirements, processes, and measure specifications for
performance measures and, once recognized, any proposed changes or
updates to these standards, and requirements, processes and measure
specifications with 60-day notice prior to public notification. This
collection, which is approved under OCN: 0938-1176), is necessary in
order for Exchanges to verify that the QHPs being offered in their
Exchange meet the accreditation requirement and are high quality plans.
The 60-day Federal Register notice published on November 23, 2012
(77 FR 70163). We received two comments. The comments concerned issuer
burden associated with the data collection and the content of the data
submission. These comments were addressed in full in the Patient
Protection and Affordable Care Act; Standards Related to Essential
Health Benefits, Actuarial Value, and Accreditation Final Rule.
Generally, we noted that this data collection pertained to the
submission of data from accrediting entities seeking to be recognized
and accrediting entities already recognized, rather than issuers.
Comments related to the content of the data submission were deemed out
of scope. Form Number: CMS-10449; Frequency: Monthly, Occasionally;
Affected Public: Private sector, Not-for-profit institutions; Number of
Respondents: 4; Number of Responses: 60; Total Annual Hours: 3,544.
(For policy questions regarding this collection contact Rebecca
Zimmermann at (301) 492-4396. For all other issues, call (410) 786-
1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS'
Web Site address at https://www.cms.hhs.gov/PaperworkReductionActof1995,
or Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov, or call
the Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received by the OMB desk
officer at the address below, no later than 5 p.m. on April 15, 2013:
OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk
Officer, Fax Number: (202) 395-6974, Email: OIRA_submission@omb.eop.gov.
Dated: March 8, 2013.
Martique Jones,
Deputy Director, Regulations Development Group, Office of Strategic
Operations and Regulatory Affairs.
[FR Doc. 2013-05802 Filed 3-13-13; 8:45 am]
BILLING CODE 4120-01-P